_id
6915f678bc934aba376b2417
Ticker
SEPSF
Name
Asep Medical Holdings Inc
Exchange
PINK
Address
4400 Chatterton Way, Victoria, BC, Canada, V8X 5J3
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://asepmedical.com
Description
ASEP Medical Holdings Inc., together with its subsidiaries, engages in the acquisition of research and development assets, technologies, and businesses in the area of life sciences and medical diagnostics. It offers peptide technologies that cover therapeutic applications, including bacterial biofilm infections, anti-inflammatory, anti-infective immune-modulators, and vaccine adjuvants; diagnostic kits for predicting the onset of severe sepsis and organ failure; and medical devices with anti-microbial and antifouling coating. The company was formerly known as Trenchant Life Sciences Investment Corp. and changed its name to ASEP Medical Holdings Inc. in November 2021. ASEP Medical Holdings Inc. was incorporated in 2021 and is headquartered in Victoria, Canada.
Last Close
0.0109
Volume
-
Current Price
0.0109
Change
0
Last Updated
2026-01-06T11:00:08.459Z
Image
data:image/webp;base64,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
Ipo Date
-
Market Cap
121248
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
74803
Cost Of Revenue
-13839
Gross Profit
88642
Operating Expenses
645976
Operating Income
-571173
Interest Expense
6593
Pretax Income
-538064
Net Income
-486405
Eps
-0.04372679341612871
Dividends Per Share
-
Shares Outstanding
11123729
Income Tax Expense
-
EBITDA
-
Operating Margin
-763.5696429287595
Total Other Income Expense Net
39702
Cash
510627
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
732970
Property Plant Equipment
14310
Total Assets
13475042
Payables
1524760
Short Term Debt
-
Long Term Debt
-
Total Liabilities
4086101
Equity
5079531
Bs_currency_symbol
CAD
Depreciation
171998
Change In Working Capital
-130923
Cash From Operations
-582685
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
102900
Net Change In Cash
469588
Cf_currency_symbol
CAD
PE
-
PB
0.02387004747091808
ROE
-9.575785638477253
ROA
-3.60967335018325
FCF
-582685
Fcf Percent
-7.789594000240632
Piotroski FScore
0
Health Score
29
Deep Value Investing Score
6
Defensive Investing Score
5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
1
Momentum Investing Score
4
Net Net Investing Score
4
Quality Investing Score
2.5
Value Investing Score
5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
74803
Quarters > 0 > income Statement > cost Of Revenue
-13839
Quarters > 0 > income Statement > gross Profit
88642
Quarters > 0 > income Statement > operating Expenses
645976
Quarters > 0 > income Statement > operating Income
-571173
Quarters > 0 > income Statement > interest Expense
6593
Quarters > 0 > income Statement > pretax Income
-538064
Quarters > 0 > income Statement > net Income
-486405
Quarters > 0 > income Statement > eps
-0.04372679341612871
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
11123729
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-763.5696429287595
Quarters > 0 > income Statement > total Other Income Expense Net
39702
Quarters > 0 > income Statement > currency_symbol
CAD
Quarters > 0 > balance Sheet > cash
510627
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
732970
Quarters > 0 > balance Sheet > property Plant Equipment
14310
Quarters > 0 > balance Sheet > total Assets
13475042
Quarters > 0 > balance Sheet > payables
1524760
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
4086101
Quarters > 0 > balance Sheet > equity
5079531
Quarters > 0 > balance Sheet > currency_symbol
CAD
Quarters > 0 > cash Flow > net Income
-486405
Quarters > 0 > cash Flow > depreciation
171998
Quarters > 0 > cash Flow > change In Working Capital
-130923
Quarters > 0 > cash Flow > cash From Operations
-582685
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
102900
Quarters > 0 > cash Flow > net Change In Cash
469588
Quarters > 0 > cash Flow > currency_symbol
CAD
Quarters > 0 > ratios > PE
-0.04372679341612871
Quarters > 0 > ratios > PB
0.02387004747091808
Quarters > 0 > ratios > ROE
-9.575785638477253
Quarters > 0 > ratios > ROA
-3.60967335018325
Quarters > 0 > ratios > FCF
-582685
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-7.789594000240632
Quarters > 0 > health Score
29
Quarters > 1 > quarter
2024-09-30
Quarters > 1 > income Statement > revenue
74803
Quarters > 1 > income Statement > cost Of Revenue
33750
Quarters > 1 > income Statement > gross Profit
41053
Quarters > 1 > income Statement > operating Expenses
926863
Quarters > 1 > income Statement > operating Income
-885810
Quarters > 1 > income Statement > interest Expense
655
Quarters > 1 > income Statement > pretax Income
-963347
Quarters > 1 > income Statement > net Income
-733367
Quarters > 1 > income Statement > eps
-0.009633597847525677
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
76125972
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-636970
Quarters > 1 > income Statement > operating Margin
-1184.1904736441052
Quarters > 1 > income Statement > total Other Income Expense Net
-77537
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
12284
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
48262
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
100948
Quarters > 1 > balance Sheet > property Plant Equipment
26934
Quarters > 1 > balance Sheet > total Assets
24300006
Quarters > 1 > balance Sheet > payables
1994674
Quarters > 1 > balance Sheet > short Term Debt
22166
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
4418777
Quarters > 1 > balance Sheet > equity
10546445
Quarters > 1 > balance Sheet > currency_symbol
CAD
Quarters > 1 > cash Flow > net Income
-963348
Quarters > 1 > cash Flow > depreciation
325721
Quarters > 1 > cash Flow > change In Working Capital
431209
Quarters > 1 > cash Flow > cash From Operations
-75604
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
62587
Quarters > 1 > cash Flow > net Change In Cash
-13017
Quarters > 1 > cash Flow > currency_symbol
CAD
Quarters > 1 > ratios > PE
-0.009633597847525677
Quarters > 1 > ratios > PB
0.07867799005257221
Quarters > 1 > ratios > ROE
-6.953689134111067
Quarters > 1 > ratios > ROA
-3.017970448237749
Quarters > 1 > ratios > FCF
-75604
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-1.0107081266794113
Quarters > 1 > health Score
34
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
73990
Quarters > 2 > income Statement > cost Of Revenue
39372
Quarters > 2 > income Statement > gross Profit
34618
Quarters > 2 > income Statement > operating Expenses
1352772
Quarters > 2 > income Statement > operating Income
-1318154
Quarters > 2 > income Statement > interest Expense
630
Quarters > 2 > income Statement > pretax Income
-1334919
Quarters > 2 > income Statement > net Income
-1122282
Quarters > 2 > income Statement > eps
-0.014742432451305843
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
76125972
Quarters > 2 > income Statement > income Tax Expense
-199349
Quarters > 2 > income Statement > EBITDA
-1007538
Quarters > 2 > income Statement > operating Margin
-1781.5299364779023
Quarters > 2 > income Statement > total Other Income Expense Net
-16765
Quarters > 2 > income Statement > currency_symbol
CAD
Quarters > 2 > balance Sheet > cash
25301
Quarters > 2 > balance Sheet > short Term Investments
101853
Quarters > 2 > balance Sheet > receivables
39634
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
166789
Quarters > 2 > balance Sheet > property Plant Equipment
30117
Quarters > 2 > balance Sheet > total Assets
24847249
Quarters > 2 > balance Sheet > payables
1056191
Quarters > 2 > balance Sheet > short Term Debt
21510
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
4051954
Quarters > 2 > balance Sheet > equity
11230531
Quarters > 2 > balance Sheet > currency_symbol
CAD
Quarters > 2 > cash Flow > net Income
-1334918
Quarters > 2 > cash Flow > depreciation
326751
Quarters > 2 > cash Flow > change In Working Capital
51169
Quarters > 2 > cash Flow > cash From Operations
-106646
Quarters > 2 > cash Flow > capital Expenditures
190
Quarters > 2 > cash Flow > cash From Investing
-190
Quarters > 2 > cash Flow > cash From Financing
113473
Quarters > 2 > cash Flow > net Change In Cash
6637
Quarters > 2 > cash Flow > currency_symbol
CAD
Quarters > 2 > ratios > PE
-0.014742432451305843
Quarters > 2 > ratios > PB
0.07388547298431392
Quarters > 2 > ratios > ROE
-9.993133895449823
Quarters > 2 > ratios > ROA
-4.516725372696189
Quarters > 2 > ratios > FCF
-106836
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-1.443924854710096
Quarters > 2 > health Score
34
Quarters > 3 > quarter
2024-03-31
Quarters > 3 > income Statement > revenue
73990
Quarters > 3 > income Statement > cost Of Revenue
327253
Quarters > 3 > income Statement > gross Profit
-253263
Quarters > 3 > income Statement > operating Expenses
663649
Quarters > 3 > income Statement > operating Income
-916910
Quarters > 3 > income Statement > interest Expense
611
Quarters > 3 > income Statement > pretax Income
-919092
Quarters > 3 > income Statement > net Income
-762028
Quarters > 3 > income Statement > eps
-0.010202312728435714
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
74691692
Quarters > 3 > income Statement > income Tax Expense
-157067
Quarters > 3 > income Statement > EBITDA
-605598
Quarters > 3 > income Statement > operating Margin
-1239.2350317610487
Quarters > 3 > income Statement > total Other Income Expense Net
-16550
Quarters > 3 > income Statement > currency_symbol
CAD
Quarters > 3 > balance Sheet > cash
18664
Quarters > 3 > balance Sheet > short Term Investments
159212
Quarters > 3 > balance Sheet > receivables
33447
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
211323
Quarters > 3 > balance Sheet > property Plant Equipment
33621
Quarters > 3 > balance Sheet > total Assets
25231632
Quarters > 3 > balance Sheet > payables
612141
Quarters > 3 > balance Sheet > short Term Debt
20881
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
3478392
Quarters > 3 > balance Sheet > equity
11975839
Quarters > 3 > balance Sheet > currency_symbol
CAD
Quarters > 3 > cash Flow > net Income
-762028
Quarters > 3 > cash Flow > depreciation
327253
Quarters > 3 > cash Flow > change In Working Capital
398675
Quarters > 3 > cash Flow > cash From Operations
-140667
Quarters > 3 > cash Flow > capital Expenditures
190
Quarters > 3 > cash Flow > cash From Investing
-190
Quarters > 3 > cash Flow > cash From Financing
94800
Quarters > 3 > cash Flow > net Change In Cash
-46057
Quarters > 3 > cash Flow > currency_symbol
CAD
Quarters > 3 > ratios > PE
-0.010202312728435714
Quarters > 3 > ratios > PB
0.06798182931483965
Quarters > 3 > ratios > ROE
-6.36304479377186
Quarters > 3 > ratios > ROA
-3.020129653127471
Quarters > 3 > ratios > FCF
-140857
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-1.9037302338153805
Quarters > 3 > health Score
34
Annuals > 0 > quarter
2023-12-31
Annuals > 0 > income Statement > revenue
21140
Annuals > 0 > income Statement > cost Of Revenue
134880
Annuals > 0 > income Statement > gross Profit
-113740
Annuals > 0 > income Statement > operating Expenses
7607523
Annuals > 0 > income Statement > operating Income
-7721263
Annuals > 0 > income Statement > interest Expense
270
Annuals > 0 > income Statement > pretax Income
-9430513
Annuals > 0 > income Statement > net Income
-8227328
Annuals > 0 > income Statement > eps
-0.13219697634329236
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
62235372
Annuals > 0 > income Statement > income Tax Expense
-1203181
Annuals > 0 > income Statement > EBITDA
-8135977
Annuals > 0 > income Statement > operating Margin
-36524.42289498581
Annuals > 0 > income Statement > total Other Income Expense Net
-1709250
Annuals > 0 > income Statement > currency_symbol
CAD
Annuals > 0 > balance Sheet > cash
64721
Annuals > 0 > balance Sheet > short Term Investments
160799
Annuals > 0 > balance Sheet > receivables
25423
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
250943
Annuals > 0 > balance Sheet > property Plant Equipment
37183
Annuals > 0 > balance Sheet > total Assets
25612686
Annuals > 0 > balance Sheet > payables
428431
Annuals > 0 > balance Sheet > short Term Debt
20270
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
3051861
Annuals > 0 > balance Sheet > equity
12611990
Annuals > 0 > balance Sheet > currency_symbol
CAD
Annuals > 0 > cash Flow > net Income
-9430513
Annuals > 0 > cash Flow > depreciation
1294266
Annuals > 0 > cash Flow > change In Working Capital
1082034
Annuals > 0 > cash Flow > cash From Operations
-2712598
Annuals > 0 > cash Flow > capital Expenditures
4471
Annuals > 0 > cash Flow > cash From Investing
-4471
Annuals > 0 > cash Flow > cash From Financing
651400
Annuals > 0 > cash Flow > net Change In Cash
-2065669
Annuals > 0 > cash Flow > currency_symbol
CAD
Annuals > 0 > ratios > PE
-0.13219697634329236
Annuals > 0 > ratios > PB
0.053787352733391
Annuals > 0 > ratios > ROE
-65.23417795288452
Annuals > 0 > ratios > ROA
-32.122082002645094
Annuals > 0 > ratios > FCF
-2717069
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-128.52738883632924
Annuals > 0 > health Score
33
Annuals > 1 > quarter
2022-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
155401
Annuals > 1 > income Statement > gross Profit
-155401
Annuals > 1 > income Statement > operating Expenses
5442652
Annuals > 1 > income Statement > operating Income
-5442653
Annuals > 1 > income Statement > interest Expense
814
Annuals > 1 > income Statement > pretax Income
-5846386
Annuals > 1 > income Statement > net Income
-4524981
Annuals > 1 > income Statement > eps
-0.08052126822971353
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
56196097
Annuals > 1 > income Statement > income Tax Expense
-89100
Annuals > 1 > income Statement > EBITDA
-3330776
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-403733
Annuals > 1 > income Statement > currency_symbol
CAD
Annuals > 1 > balance Sheet > cash
2130390
Annuals > 1 > balance Sheet > short Term Investments
1153636
Annuals > 1 > balance Sheet > receivables
114619
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
3398645
Annuals > 1 > balance Sheet > property Plant Equipment
50204
Annuals > 1 > balance Sheet > total Assets
27078589
Annuals > 1 > balance Sheet > payables
478661
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
528161
Annuals > 1 > balance Sheet > equity
15470000
Annuals > 1 > balance Sheet > currency_symbol
CAD
Annuals > 1 > cash Flow > net Income
-5757286
Annuals > 1 > cash Flow > depreciation
1282394
Annuals > 1 > cash Flow > change In Working Capital
-420139
Annuals > 1 > cash Flow > cash From Operations
-3614476
Annuals > 1 > cash Flow > capital Expenditures
435
Annuals > 1 > cash Flow > cash From Investing
124796
Annuals > 1 > cash Flow > cash From Financing
330000
Annuals > 1 > cash Flow > net Change In Cash
-3159680
Annuals > 1 > cash Flow > currency_symbol
CAD
Annuals > 1 > ratios > PE
-0.08052126822971353
Annuals > 1 > ratios > PB
0.039595181467356175
Annuals > 1 > ratios > ROE
-29.25003878474467
Annuals > 1 > ratios > ROA
-16.710549430769824
Annuals > 1 > ratios > FCF
-3614911
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
33
Annuals > 2 > quarter
2021-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
177177
Annuals > 2 > income Statement > gross Profit
-177177
Annuals > 2 > income Statement > operating Expenses
1977625
Annuals > 2 > income Statement > operating Income
-1977625
Annuals > 2 > income Statement > interest Expense
102000
Annuals > 2 > income Statement > pretax Income
-2343563
Annuals > 2 > income Statement > net Income
-2200086
Annuals > 2 > income Statement > eps
-0.03919601846730175
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
56130344
Annuals > 2 > income Statement > income Tax Expense
-41478
Annuals > 2 > income Statement > EBITDA
-1918327
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-289549
Annuals > 2 > income Statement > currency_symbol
CAD
Annuals > 2 > balance Sheet > cash
5290070
Annuals > 2 > balance Sheet > short Term Investments
390761
Annuals > 2 > balance Sheet > receivables
73398
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
5754229
Annuals > 2 > balance Sheet > property Plant Equipment
64043
Annuals > 2 > balance Sheet > total Assets
30716132
Annuals > 2 > balance Sheet > payables
144204
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
144204
Annuals > 2 > balance Sheet > equity
18259194
Annuals > 2 > balance Sheet > currency_symbol
CAD
Annuals > 2 > cash Flow > net Income
-2343563
Annuals > 2 > cash Flow > depreciation
177177
Annuals > 2 > cash Flow > change In Working Capital
-319995
Annuals > 2 > cash Flow > cash From Operations
-1191064
Annuals > 2 > cash Flow > capital Expenditures
115722
Annuals > 2 > cash Flow > cash From Investing
146082
Annuals > 2 > cash Flow > cash From Financing
6335052
Annuals > 2 > cash Flow > net Change In Cash
5281600
Annuals > 2 > cash Flow > currency_symbol
CAD
Annuals > 2 > ratios > PE
-0.03919601846730175
Annuals > 2 > ratios > PB
0.03350754417747026
Annuals > 2 > ratios > ROE
-12.04919559976196
Annuals > 2 > ratios > ROA
-7.162640139715508
Annuals > 2 > ratios > FCF
-1306786
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
33
Annuals > 3 > quarter
2020-12-31
Annuals > 3 > income Statement > revenue
-
Annuals > 3 > income Statement > cost Of Revenue
26451
Annuals > 3 > income Statement > gross Profit
-26451
Annuals > 3 > income Statement > operating Expenses
1646
Annuals > 3 > income Statement > operating Income
-28097
Annuals > 3 > income Statement > interest Expense
-
Annuals > 3 > income Statement > pretax Income
-28097
Annuals > 3 > income Statement > net Income
-28097
Annuals > 3 > income Statement > eps
-0.0018850018073797447
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
14905556
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-
Annuals > 3 > income Statement > currency_symbol
-
Annuals > 3 > balance Sheet > cash
8470
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
10980
Annuals > 3 > balance Sheet > property Plant Equipment
-
Annuals > 3 > balance Sheet > total Assets
10980
Annuals > 3 > balance Sheet > payables
20796
Annuals > 3 > balance Sheet > short Term Debt
140714
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
161510
Annuals > 3 > balance Sheet > equity
-150530
Annuals > 3 > balance Sheet > currency_symbol
-
Annuals > 3 > cash Flow > net Income
-28097
Annuals > 3 > cash Flow > depreciation
28097
Annuals > 3 > cash Flow > change In Working Capital
-450
Annuals > 3 > cash Flow > cash From Operations
-22122
Annuals > 3 > cash Flow > capital Expenditures
0
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
30058
Annuals > 3 > cash Flow > net Change In Cash
7936
Annuals > 3 > cash Flow > currency_symbol
-
Annuals > 3 > ratios > PE
-0.0018850018073797447
Annuals > 3 > ratios > PB
-1.07932345977546
Annuals > 3 > ratios > ROE
18.665382315817443
Annuals > 3 > ratios > ROA
-255.89253187613843
Annuals > 3 > ratios > FCF
-22122
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
36
Valuation > metrics > PE
-0.04372679341612871
Valuation > metrics > PB
0.02387004747091808
Valuation > final Score
70
Valuation > verdict
97.6% Undervalued
Profitability > metrics > ROE
-9.575785638477253
Profitability > metrics > ROA
-66.36083332196407
Profitability > metrics > Net Margin
-6.502479847064957
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.8044248573342696
Risk > metrics > Interest Coverage
-86.63324738358865
Risk > final Score
-299
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.48071171856554473
Liquidity > metrics > Quick Ratio
0.48071171856554473
Liquidity > final Score
34
Liquidity > verdict
Weak
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-5350
Prev Risks > 1
-8309
Prev Risks > 2
-5943
Prev Liquidities > 0
13
Prev Liquidities > 1
18
Prev Liquidities > 2
27
Updated At
2026-01-20T22:33:00.984Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-09-30
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.0317
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-06-30
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.071
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-03-31
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.0534
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2024-12-31
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.5212
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-09-30
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
CAD
Earnings History > 4 > eps Actual
-0.0703
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-06-30
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
CAD
Earnings History > 5 > eps Actual
-0.1077
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-03-31
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
CAD
Earnings History > 6 > eps Actual
-0.0757
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2023-12-31
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
CAD
Earnings History > 7 > eps Actual
-0.1997
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-09-30
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
CAD
Earnings History > 8 > eps Actual
-0.1541
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-06-30
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
CAD
Earnings History > 9 > eps Actual
-0.3094
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-03-31
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
CAD
Earnings History > 10 > eps Actual
-0.2441
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2022-12-31
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
CAD
Earnings History > 11 > eps Actual
-0.1444
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-09-30
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
CAD
Earnings History > 12 > eps Actual
-0.1026
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-06-30
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
CAD
Earnings History > 13 > eps Actual
-0.1609
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-03-31
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
CAD
Earnings History > 14 > eps Actual
-0.1972
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
ASEP Medical Holdings Inc., together with its subsidiaries, engages in the acquisition of research and development assets, technologies, and businesses in the area of life sciences and medical diagnostics. It offers peptide technologies that cover therapeutic applications, including bacterial biofilm infections, anti-inflammatory, anti-infective immune-modulators, and vaccine adjuvants; diagnostic kits for predicting the onset of severe sepsis and organ failure; and medical devices with anti-microbial and antifouling coating. The company was formerly known as Trenchant Life Sciences Investment Corp. and changed its name to ASEP Medical Holdings Inc. in November 2021. ASEP Medical Holdings Inc. was incorporated in 2021 and is headquartered in Victoria, Canada.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AAsep Medical Holdings Inc. Announces Listing of its Common Shares on the Frankfurt Stock Exchange Nasdaq
Read more →(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Asep Medical Holdings Inc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.0317
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.